GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Witty has told GSK's board that he intends to retire ...

GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.

The big picture: UnitedHealth Group CEO Andrew Witty spoke at length Thursday about ... The intrigue: Witty is a former CEO of British drug company GSK. During his tenure there, he told CNBC ...

The company's decision comes at a time when GSK faces allegations of illegal payments to Chinese doctors and officials. CEO Andrew Witty is likely to give his perspective on what appears to have ...

In an interview with WSJ's Dennis Berman, GlaxoSmithKline CEO Andrew Witty discusses why the drug maker has devoted time to researching a malaria vaccine for children in Africa -- and why he ...